Cite
HARVARD Citation
Sartor, C. et al. (2022). Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment. Hematological oncology. 40 (4), pp. 734-742. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sartor, C. et al. (2022). Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment. Hematological oncology. 40 (4), pp. 734-742. [Online].